Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
Clinical trial NCT03820830 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03820830
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-27
- Primary completion
- 2026-07-27
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.